276 related articles for article (PubMed ID: 36217874)
1. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
Sonday F; Bheekie A; Van Huyssteen M
S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
3. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
4. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
LaMarr B; Valdez C; Driscoll K; Ryan M
Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria.
Ipingbemi AE; Erhun WO; Adisa R
BMC Health Serv Res; 2021 Sep; 21(1):1000. PubMed ID: 34551779
[TBL] [Abstract][Full Text] [Related]
6. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.
Oonk NGM; Dorresteijn LDA; Te Braake E; Movig KLL; van der Palen J; Nijmeijer HW; van Kesteren ME; Bode C
Ther Adv Drug Saf; 2024; 15():20420986241237071. PubMed ID: 38694547
[TBL] [Abstract][Full Text] [Related]
7. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
8. Medication Therapy Management for Texas MediCAID Patients With Asthma and Chronic Obstructive Pulmonary Disease-A Pilot Study.
Nduaguba S; Barner JC; Makhinova T; Roberson K
J Pharm Pract; 2022 Aug; 35(4):528-535. PubMed ID: 33648367
[TBL] [Abstract][Full Text] [Related]
9. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
10. Independent pharmacist prescribing of statins for patients with type 2 diabetes: An analysis of enhanced pharmacist prescriptive authority in Idaho.
Spann N; Hamper J; Griffith R; Cleveland K; Flynn T; Jindrich K
J Am Pharm Assoc (2003); 2020; 60(3S):S108-S114.e1. PubMed ID: 32127253
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams.
Samir Abdin M; Grenier-Gosselin L; Guénette L
Int J Pharm Pract; 2020 Feb; 28(1):75-83. PubMed ID: 31468599
[TBL] [Abstract][Full Text] [Related]
12. Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews.
Morrison C; MacRae Y
Drugs Real World Outcomes; 2015 Sep; 2(3):261-271. PubMed ID: 27747572
[TBL] [Abstract][Full Text] [Related]
13. Improving primary care antimicrobial stewardship by implementing a peer audit and feedback intervention in Cape Town community healthcare centres.
De Vries E; Johnson Y; Willems B; Bedeker W; Ras T; Coetzee R; Tembo Y; Brink A
S Afr Med J; 2022 Oct; 112(10):812-818. PubMed ID: 36472332
[TBL] [Abstract][Full Text] [Related]
14. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
[TBL] [Abstract][Full Text] [Related]
15. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
16. Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
Negash Z; Berha AB; Shibeshi W; Ahmed A; Woldu MA; Engidawork E
PLoS One; 2021; 16(6):e0251709. PubMed ID: 34077431
[TBL] [Abstract][Full Text] [Related]
17. The Pharmacist's role in dermatology: Patient medication adherence.
Pathak GN; Chandy RJ; Shah R; Feldman SR
J Dermatol; 2023 Sep; 50(9):1099-1107. PubMed ID: 37489577
[TBL] [Abstract][Full Text] [Related]
18. Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care.
Aidit S; Soh YC; Yap CS; Khan TM; Neoh CF; Shaharuddin S; Kassab YW; Patel RP; Ming LC
Front Pharmacol; 2017; 8():637. PubMed ID: 29170637
[No Abstract] [Full Text] [Related]
19. Community pharmacists' interventions and documentation during medication therapy management encounters delivered face-to-face versus via telephone: The devil is in the details.
Rivera J; Shcherbakova N; Vala C; Capoccia K
Res Social Adm Pharm; 2020 Oct; 16(10):1447-1451. PubMed ID: 31889640
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
